271
Views
9
CrossRef citations to date
0
Altmetric
Articles

Effects of karanjin on dimethylhydrazine induced colon carcinoma and aberrant crypt foci are facilitated by alteration of the p53/Bcl2/BAX pathway for apoptosis

, , & ORCID Icon

References

  • Bird RP, Good K. 2000. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett. 112–113:395–402.
  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394. doi:10.3322/caac.21492.
  • Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. 2016. Cancer statistics in China, 2016. CA Cancer J Clin. 66:115–132. doi:10.3322/caac.21338.
  • Elhafey AS, Papadimitriou JC, El-Hakim MS, El-Said AI, Ghannam BB, Silverberg SG. 2001. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium. Arch Pathol Lab Med. 125:872–879. doi:10.1043/0003-9985(2001)125<0872:CIAOPA>2.0.CO;2.
  • Fischer AH, Jacobson KA, Rose J, Zeller R. 2008. Hematoxylin and eosin staining of tissue and cell sections. C S Harb Protoc. 6:1–3.
  • Guo JR, Chen QQ, Lam CWK, Zhang W. 2015. Effects of karanjin on cell cycle arrest and apoptosis in human A549, HepG2 and HL‑60 cancer cells. Biol Res. 48:1–10. doi:10.1186/s40659-015-0031-x.
  • Hajrezaie M, Hassandarvish P, Moghadamtousi SZ, Gwara NS, Golbabapour S, Najihussien A, Almagrami AA, Zahedifard M, Rouhollahi E, Karimian H, Fani S, Kamalidehghan B, Majid NA, Ali HM, Abdulla MA. 2014. Chemopreventive evaluation of a Schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in rats. PLoS One. 9:e91246. doi:10.1371/journal.pone.0091246.
  • Jaiswal N, Yadav PP, Maurya R, Srivastava AK, Tamrakar AK. 2011. Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner. Eur J Pharmacol. 670:22–28. doi:10.1016/j.ejphar.2011.08.049.
  • Janne PA, Mayer RJ. 2000. Chemoprevention of colorectal cancer. N Engl J Med. 342:1960–1968. doi:10.1056/NEJM200006293422606.
  • Kakkar P, Das B, Viswanthan PN. 1984. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys. 21:130–132.
  • Karthik Kumar V, Vennila S, Nalini N. 2009. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer. Food Chem Toxicol. 47:309–315. doi:10.1016/j.fct.2008.11.017.
  • Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell. 88:323–331. doi:10.1016/S0092-8674(00)81871-1.
  • Maurya R, Yadav PP. 2005. Furanoflavonoids: an overview (review). Nat Prod Rep. 22:400–424. doi:10.1039/b505071p.
  • Michaelis M, Rothweiler F, Nerreter T, Sharifi M, Ghafourian T, Cinatl J. 2014. Karanjin interferes with ABCB1, ABCC1, and ABCG2. J Pharm Sci. 17:92–105.
  • Moreno I, Pichardo S, Jos A, Gómez-Amores L, Mate A, Vazquez CM, Cameán AM. 2005. Antioxidant enzyme activity and lipid peroxidation in liver and kidney of rats exposed to microcystin-LR administered intraperitoneally. Toxicon. 45:395–402. doi:10.1016/j.toxicon.2004.11.001.
  • Narendhirakannan RT, Subramanian S, Kandaswamy M. 2005. Free radical scavenging activity of Cleome gynandra L. leaves on adjuvant induced arthritis in rats. Mol Cell Biochem. 276:71–80. doi:10.1007/s11010-005-3234-6.
  • Newman DJ, Cragg GM. 2007. Natural products as sources of new drugs over the last 25 years. J Nat Prod. 70:461–477. doi:10.1021/np068054v.
  • Newman DJ, Cragg GM. 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod. 75:311–335. doi:10.1021/np200906s.
  • Patel PP, Trivedi ND. 2017. Effect of karanjin on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Balb/c mice. Ind J Pharmacol. 49:161–167.
  • Ray RS, Roy S, Samanta S, Maitra D, Chatterjee M. 2004. Protective role of vanadium on early process of rat mammary carcinogenesis by influencing expression of metallothionein, GGT‐positive foci and DNA fragmentation. Cell Biochem Funct. 23:447‐456.
  • Roy S, Das R, Ghosh B, Chakraborty T. 2018. Deciphering the biochemical and molecular mechanism underlying the in-vitro and in-vivo chemotherapeutic efficacy of ruthenium quercetin complex in colon cancer. Mol Carcinogen. 57:700–721. doi:10.1002/mc.22792.
  • Roy S, Sil A, Chakraborty T. 2019. Potentiating apoptosis and modulation of p53, Bcl2, and BAX by a novel chrysin ruthenium complex for effective chemotherapeutic efficacy against breast cancer. J Cell Physiol. 234:4888–4909. doi:10.1002/jcp.27287.
  • Seyyedi MA, Farahnak A, Jalali M, Rokni MB. 2005. Study on glutathione S-transferase (GST) inhibition assay by triclabendazole. Protoscoleces (hydatid cyst; Echinococcus granulosus) and sheep liver tissue. Iran J Publ Health. 34:38–46.
  • Tamrakar AK, Yadav PP, Tiwari P, Maurya R, Srivastava AK. 2008. Identification of pongamol and karanjin as lead compounds with antihyperglycemic activity from Pongamia pinnata fruits. J Ethnopharmacol. 118:435–439. doi:10.1016/j.jep.2008.05.008.
  • Vismaya Belagihally SM, Rajashekhar S, Jayaram VB, Dharmesh SM, Thirumakudalu SKC. 2011. Gastroprotective properties of karanjin from karanja (Pongamia pinnata) seeds; role as antioxidant and H+, K+-ATPase inhibitor. Evid Based Comple Alt Med. Article ID:747246.
  • Wang J, Qi L, Zheng S, Wu T. 2009. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B. 10:93–102. doi:10.1631/jzus.B0820238.
  • Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, Wan X, Yu S, Jiang Y, Naghavi M, Vos T, Wang H, Lopez AD, Murray CJ. 2013. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 381:1987–2015. doi:10.1016/S0140-6736(13)61097-1.
  • Yoshimi K, Hashimoto T, Niwa Y, Hata K, Serikawa T, Tanaka T, Kuramoto T. 2012. Use of a chemically induced colon carcinogenesis-prone Apc-mutant rat in a chemotherapeutic bioassay. BMC Cancer. 12:1–13. doi:10.1186/1471-2407-12-448.
  • Zhang L, Cao F, Zhang G, Shi L, Chen S, Zhang Z, Zhi W, Ma T. 2019. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025. Front Oncol. 9:1–9. doi:10.3389/fonc.2019.00001.
  • Zhuo Z, Hu J, Yang X, Chen M, Lei X, Deng L, Yao N, Peng Q, Chen Z, Ye W, Zhang D. 2015. Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci Rep. 5:1–18. doi:10.1038/srep16185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.